Study: Ongoing, but not recruiting participants
ClinicalTrials.gov Identifier: NCT01969708
Score2: Study of Comparative Treatments for Retinal Vein Occlusion 2 [Score 2]: a multi-center, prospective, randomized non-inferiority trial of eyes with macular edema secondary to central retinal vein occlusion, comparing intravitreal bevacizumab every 4 weeks with intravitreal aflibercept every 4 weeks.
Condition: Central Retinal Vein Occlusion
Study Type: Interventional
Duration: 12 months
For additional information on this study, please click hereBack to Clinical Research